Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CCC Intelligent Solutions | CCCS | Jan 17, 2025 | 11.20 | +0.81 |
CCSC Technology International A | CCTG | Jan 17, 2025 | 1.73 | +1.76 |
CDT Environmental Technology Investment Holdings | CDTG | Jan 17, 2025 | 1.37 | +9.95 |
CDW | CDW | Jan 17, 2025 | 188.73 | +0.50 |
CEA Industries | CEAD | Jan 17, 2025 | 7.60 | -1.94 |
CECO Environmental | CECO | Jan 17, 2025 | 29.60 | -7.93 |
Cedar Realty Trust B Pref | CDR-B | Jan 17, 2025 | 15.85 | +2.59 |
Cedar Realty Trust C Pref | CDR-C | Jan 17, 2025 | 14.74 | +0.14 |
CEF Income Composite Powershares | PCEF | Jan 17, 2025 | 19.66 | +0.72 |
Cel-Sci | CVM | Jan 17, 2025 | 0.40 | +0.90 |
Celanese | CE | Jan 17, 2025 | 72.61 | +0.99 |
Celcuity | CELC | Jan 17, 2025 | 10.93 | -2.84 |
Celestica | CLS | Jan 17, 2025 | 113.28 | +2.31 |
Celldex Therapeutics | CLDX | Jan 17, 2025 | 23.78 | +4.48 |
Cellebrite | CLBT | Jan 17, 2025 | 22.78 | -0.87 |
Cellectar Biosciences | CLRB | Jan 17, 2025 | 0.24 | +0.54 |
Cellectis ADR | CLLS | Jan 17, 2025 | 1.48 | -1.99 |
Celsius | CELH | Jan 17, 2025 | 27.23 | -1.30 |
Celularity A | CELU | Jan 17, 2025 | 2.30 | +4.55 |
Cementos Pacasmayo ADR | CPAC | Jan 17, 2025 | 5.70 | 0.00 |
CEMEX ADR | CX | Jan 17, 2025 | 5.36 | -1.65 |
Cemtrex | CETX | Jan 17, 2025 | 2.92 | -5.19 |
Cencora | COR | Jan 17, 2025 | 242.05 | +0.48 |
Cenntro | CENN | Jan 17, 2025 | 1.20 | -0.83 |
Cenovus Energy | CVE | Jan 17, 2025 | 15.06 | +1.48 |
Centene | CNC | Jan 17, 2025 | 62.25 | -0.99 |
CenterPoint Energy | CNP | Jan 17, 2025 | 32.56 | -0.73 |
Centerra Gold | CGAU | Jan 17, 2025 | 5.82 | -0.34 |
Centerspace | CSR-C | Jan 17, 2025 | 24.98 | 0.00 |
Centessa Pharmaceuticals ADR | CNTA | Jan 17, 2025 | 15.16 | +1.95 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.